These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping. Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635 [TBL] [Abstract][Full Text] [Related]
4. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Silverberg MS; Mirea L; Bull SB; Murphy JE; Steinhart AH; Greenberg GR; McLeod RS; Cohen Z; Wade JA; Siminovitch KA Inflamm Bowel Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12656131 [TBL] [Abstract][Full Text] [Related]
5. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763 [TBL] [Abstract][Full Text] [Related]
6. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Orchard TR; Thiyagaraja S; Welsh KI; Wordsworth BP; Hill Gaston JS; Jewell DP Gastroenterology; 2000 Feb; 118(2):274-8. PubMed ID: 10648455 [TBL] [Abstract][Full Text] [Related]
7. [Inflammatory bowel disease: genotype-fenotype relationship]. Gómez de la Concha E An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638 [TBL] [Abstract][Full Text] [Related]
8. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679 [TBL] [Abstract][Full Text] [Related]
9. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305 [TBL] [Abstract][Full Text] [Related]
11. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. Ferraris A; Torres B; Knafelz D; Barabino A; Lionetti P; de Angelis GL; Iacono G; Papadatou B; D'Amato G; Di Ciommo V; Dallapiccola B; Castro M Inflamm Bowel Dis; 2006 May; 12(5):355-61. PubMed ID: 16670523 [TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Török HP; Glas J; Tonenchi L; Lohse P; Müller-Myhsok B; Limbersky O; Neugebauer C; Schnitzler F; Seiderer J; Tillack C; Brand S; Brünnler G; Jagiello P; Epplen JT; Griga T; Klein W; Schiemann U; Folwaczny M; Ochsenkühn T; Folwaczny C Gut; 2005 Oct; 54(10):1421-7. PubMed ID: 15955786 [TBL] [Abstract][Full Text] [Related]
14. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Noble CL; Nimmo ER; Drummond H; Smith L; Arnott ID; Satsangi J Gut; 2005 Oct; 54(10):1416-20. PubMed ID: 15843420 [TBL] [Abstract][Full Text] [Related]
15. Contribution of IBD5 locus to clinical features of IBD patients. Latiano A; Palmieri O; Valvano RM; D'Incà R; Vecchi M; Ferraris A; Sturniolo GC; Spina L; Lombardi G; Dallapiccola B; Andriulli A; Devoto M; Annese V Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837 [TBL] [Abstract][Full Text] [Related]
16. NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease. Aldhous MC; Nimmo ER; Satsangi J Gut; 2003 Nov; 52(11):1533-5. PubMed ID: 14570717 [No Abstract] [Full Text] [Related]
17. The role of genetics in inflammatory bowel disease. Henckaerts L; Figueroa C; Vermeire S; Sans M Curr Drug Targets; 2008 May; 9(5):361-8. PubMed ID: 18473763 [TBL] [Abstract][Full Text] [Related]
18. Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations. Annese V; Latiano A; Palmieri O; Li HH; Forabosco P; Ferraris A; Andriulli A; Vecchi M; Ardizzone S; Cottone M; Dallapiccola B; Rappaport E; Fortina P; Devoto M J Med Genet; 2003 Nov; 40(11):837-41. PubMed ID: 14627676 [No Abstract] [Full Text] [Related]
19. Genetic determinants associated with early age of diagnosis of IBD. Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710 [TBL] [Abstract][Full Text] [Related]
20. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]